Prevention of postoperative thromboemboli by combined treatment with low-molecular-weight dextran and a proteinase inhibitor. A study with use of thromboelastogram
- PMID: 5543546
- PMCID: PMC1397141
- DOI: 10.1097/00000658-197101000-00026
Prevention of postoperative thromboemboli by combined treatment with low-molecular-weight dextran and a proteinase inhibitor. A study with use of thromboelastogram
Similar articles
-
Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran.Bull Exp Biol Med. 2017 Feb;162(4):462-465. doi: 10.1007/s10517-017-3640-2. Epub 2017 Feb 27. Bull Exp Biol Med. 2017. PMID: 28243911
-
Failure of low molecular weight dextran to prevent clotting during continuous renal replacement therapy.ASAIO J. 1995 Oct-Dec;41(4):847-9. ASAIO J. 1995. PMID: 8589465 Clinical Trial.
-
[Coagulation-physiological studies on the prevention of thromboembolism with dextran 60. II. Changes in coagulation and fibrinolysis].Infusionsther Klin Ernahr. 1977 Oct;4(5):299-303. Infusionsther Klin Ernahr. 1977. PMID: 562322 German.
-
[Drug prophylaxis and therapy of thromboembolism].Gynakologe. 1988 Mar;21(1):63-71. Gynakologe. 1988. PMID: 2453401 Review. German. No abstract available.
-
Prevention of venous thromboembolism.Clin Haematol. 1981 Jun;10(2):543-82. Clin Haematol. 1981. PMID: 6172228 Review. No abstract available.
Cited by
-
Monitoring heparin therapy with thromboelastography and activated partial thromboplastin time.World J Surg. 1980 May;4(3):323-30. doi: 10.1007/BF02393392. World J Surg. 1980. PMID: 7415185 No abstract available.
-
Heparin treatment in abruptio placentae.Can Med Assoc J. 1974 May 18;110(10):1159-64. Can Med Assoc J. 1974. PMID: 4829841 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources